Company TapImmune Inc. OTC Bulletin Board
Equities
TPIV
US8760334081
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 9 | 100.0 % | 3 | 100.0 % | -63.26% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 19-10-31 |
Chief Tech/Sci/R&D Officer | 51 | 18-10-22 | |
Chief Administrative Officer | - | 15-08-31 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 20-12-31 |
Nadia Agopyan
LAW | General Counsel | 62 | 19-08-14 |
General Counsel | 67 | 18-10-22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 18-10-16 |
Steven Elms
BRD | Director/Board Member | 60 | 19-08-05 |
Katharine Knobil
BRD | Director/Board Member | 60 | 21-12-07 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 18-10-16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 8,919,095 | 7,830,643 ( 87.80 %) | 0 | 87.80 % |
Company contact information
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.com![address TapImmune Inc.(TPIV)](https://cdn.zonebourse.com/static/address/31370463.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+23.50% | 45.01B | |
+47.19% | 40.96B | |
-5.16% | 38.62B | |
+36.37% | 32.6B | |
-7.79% | 27.49B | |
+18.06% | 27.17B | |
+47.29% | 14.61B | |
+41.91% | 12.95B | |
-1.02% | 11.36B |